Overweight induced Hypogonadism as major factor for the generation and or perpet...
Overweight induced Hypogonadism as major factor for the generation and or perpetuation of Metabolic Co morbidities of Obesity Contribution of Epigenetic Regulatory Mechanisms
Obesity is a global health problem whose prevalence is increasing substantially due to lifestyle changes. This complex medical condition is frequently linked to serious metabolic complications and deregulation of hormonal axes, wh...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2014-56995-JIN
HIPOGONADISMO INDUCIDO POR SOBREPESO COMO PRINCIPAL FACTOR E...
204K€
Cerrado
DOPA-Kiss
Dissecting the Brain Basis of Obesity Induced Pubertal Alter...
2M€
Cerrado
BFU2011-25021
PUBERTAD - NUEVOS SISTEMAS DE REGULACION POR NEUROPEPTIDOS Y...
357K€
Cerrado
PID2021-128372OB-I00
PAPEL DE LOS MICROARNS HIPOTALAMICOS EN LAS ALTERACIONES MET...
206K€
Cerrado
PID2020-118660GB-I00
MECANISMOS SENSORES DEL ESTADO METABOLICO Y NUTRICIONAL EN N...
468K€
Cerrado
Duración del proyecto: 42 meses
Fecha Inicio: 2015-03-27
Fecha Fin: 2018-09-30
Líder del proyecto
UNIVERSIDAD DE CÓRDOBA
No se ha especificado una descripción o un objeto social para esta compañía.
Total investigadores1414
Presupuesto del proyecto
158K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Obesity is a global health problem whose prevalence is increasing substantially due to lifestyle changes. This complex medical condition is frequently linked to serious metabolic complications and deregulation of hormonal axes, which lead to perturbed homeostasis in conditions of overweight. Different studies have suggested that obesity is often associated to hypogonadism, a reproductive disorder that might also promote metabolic alterations, thus setting a vicious circle in the generation/perpetuation of obesity co-morbidities. While the targets and molecular mechanisms underlying this phenomenon are still unknown, emerging evidence from experimental models of metabolic stress linked to hypogonadism strongly suggests the potential role of perturbations of hypothalamic Kiss1/NKB neurons. Likewise, the recently identified involvement of epigenetics in the control of Kiss1 expression at puberty, a crucial stage in sexual development that is metabolically gated, suggests also the contribution of these regulatory mechanisms to this phenomenon. In this context, this project aims to elucidate the pathophysiological relevance of epigenetic regulatory mechanisms in obesity-induced hypogonadism and their influence in the generation/ maintenance of the metabolic complications of overweight. To this end, we will characterize the time-course of alterations of key hormonal and epigenetic factors in preclinical models of obesity and will evaluate the contribution of epigenetic modifications in deregulation of hypothalamic Kiss1/NKB neurons in conditions of overweight. In addition, we will analyse the potential role of gonadal steroids in this phenomenon. This project will help to identify the molecular targets and epigenetic mechanisms responsible for the metabolic perturbations linked to obesity-induced hypogonadism, and will aid to define better tools for the treatment of these complications.